Having shown that YM155 treatment induces PARP-1-dependent parthanatos cell death in esophageal cancer cells in vitro, we next investigated the efficacy of YM155 in inhibiting KYSE410 and KYSE150 tumor growth in a mouse xenograft model of esophageal cancer. This evidence concerns the gene PARP1 and neoplasm.